Wall Street brokerages expect that Henry Schein, Inc. (NASDAQ:HSIC) will announce $1.01 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Nine analysts have issued estimates for Henry Schein’s earnings. The lowest EPS estimate is $0.97 and the highest is $1.03. Henry Schein posted earnings per share of $0.87 during the same quarter last year, which would indicate a positive year over year growth rate of 16.1%. The company is scheduled to announce its next earnings report before the market opens on Tuesday, November 6th.

According to Zacks, analysts expect that Henry Schein will report full year earnings of $4.12 per share for the current year, with EPS estimates ranging from $4.10 to $4.17. For the next financial year, analysts anticipate that the business will report earnings of $4.48 per share, with EPS estimates ranging from $4.32 to $4.55. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research analysts that follow Henry Schein.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Monday, August 6th. The company reported $1.04 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.01 by $0.03. The company had revenue of $3.33 billion for the quarter, compared to the consensus estimate of $3.31 billion. Henry Schein had a net margin of 3.15% and a return on equity of 20.40%. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.88 earnings per share.

A number of research analysts recently weighed in on the stock. Zacks Investment Research upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $86.00 price objective on the stock in a research report on Wednesday, July 25th. Stifel Nicolaus upped their target price on shares of Henry Schein from $76.00 to $81.00 and gave the company a “hold” rating in a report on Tuesday, August 7th. BidaskClub raised shares of Henry Schein from a “hold” rating to a “buy” rating in a report on Thursday, July 26th. Barrington Research reaffirmed a “buy” rating and set a $92.00 target price on shares of Henry Schein in a report on Tuesday, August 7th. Finally, Goldman Sachs Group initiated coverage on shares of Henry Schein in a report on Saturday. They set a “hold” rating and a $78.00 target price for the company. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and ten have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $83.53.

Henry Schein stock traded down $1.70 during midday trading on Wednesday, reaching $80.03. 885,269 shares of the company traded hands, compared to its average volume of 1,579,557. The company has a market cap of $12.56 billion, a price-to-earnings ratio of 22.23, a price-to-earnings-growth ratio of 2.36 and a beta of 0.97. Henry Schein has a 12 month low of $62.56 and a 12 month high of $90.52. The company has a quick ratio of 0.68, a current ratio of 1.29 and a debt-to-equity ratio of 0.34.

Hedge funds and other institutional investors have recently made changes to their positions in the company. NEXT Financial Group Inc purchased a new stake in shares of Henry Schein in the third quarter worth $103,000. McAdam LLC purchased a new stake in shares of Henry Schein in the third quarter worth $104,000. Squar Milner Financial Services LLC purchased a new stake in shares of Henry Schein in the second quarter worth $120,000. Piedmont Investment Advisors LLC purchased a new stake in shares of Henry Schein in the second quarter worth $130,000. Finally, Fuller & Thaler Asset Management Inc. increased its stake in shares of Henry Schein by 57.1% in the second quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock worth $160,000 after purchasing an additional 800 shares in the last quarter.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading: Bear Market – How and Why They Occur

Get a free copy of the Zacks research report on Henry Schein (HSIC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.